186 related articles for article (PubMed ID: 38148013)
41. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
42. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals.
Al-Salam S; John A; Daoud S; Chong SM; Castella A
Leuk Lymphoma; 2008 Sep; 49(9):1769-77. PubMed ID: 18661399
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients.
Pereira V; Boudjemaa S; Besson C; Leblanc T; Rigaud C; Leruste A; Garnier N; Lambilliotte A; Simonin M; Curtillet C; Bonneau-Lagacherie J; Coulomb A; Landman-Parker J
J Pediatr Hematol Oncol; 2022 Nov; 44(8):e1033-e1038. PubMed ID: 35091521
[TBL] [Abstract][Full Text] [Related]
44. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
[No Abstract] [Full Text] [Related]
45. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
[TBL] [Abstract][Full Text] [Related]
46. Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
Carbone A; Gloghini A; Carlo-Stella C
Blood; 2018 Jul; 132(1):17-22. PubMed ID: 29716887
[TBL] [Abstract][Full Text] [Related]
47. Association of the Epstein-Barr viruses with Hodgkin lymphoma: an analysis of pediatric cases in Thailand.
Hemsrichart V; Pintong J
J Med Assoc Thai; 2005 Jun; 88(6):782-7. PubMed ID: 16083219
[TBL] [Abstract][Full Text] [Related]
48. The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease.
Kandil A; Bazarbashi S; Mourad WA
Cancer; 2001 Jun; 91(11):1957-63. PubMed ID: 11391573
[TBL] [Abstract][Full Text] [Related]
49. Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia.
Dhiab MB; Ziadi S; Saad H; Louhichi T; Trimeche M
Ann Hematol; 2016 Sep; 95(9):1537-43. PubMed ID: 27378019
[TBL] [Abstract][Full Text] [Related]
50. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.
Chang KC; Khen NT; Jones D; Su IJ
Hum Pathol; 2005 Jul; 36(7):747-55. PubMed ID: 16084943
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
53. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
54. [Hodgkin's disease and Epstein-Barr virus].
Depil S; Moralès O; Auriault C
Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.
Audouin J; Diebold J; Nathwani B; Ishak E; Maclennan K; Mueller-Hermelink HK; Armitage JO; Weisenburger DD
J Hematop; 2010 Jun; 3(1):11-8. PubMed ID: 21625283
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma.
Liu Z; Jarrett RF; Hjalgrim H; Proietti C; Chang ET; Smedby KE; Yu KJ; Lake A; Troy S; McAulay KA; Pfeiffer RM; Adami HO; Glimelius B; Melbye M; Hildesheim A; Doolan DL; Coghill AE
Int J Cancer; 2020 Aug; 147(3):608-618. PubMed ID: 31618442
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadié M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini RM; Adami HO; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjønneland A; Melin B; Canzian F; Khaw KT; Travis RC; Peeters PH; González CA; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjosé S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
J Natl Cancer Inst; 2012 Feb; 104(3):240-53. PubMed ID: 22286212
[TBL] [Abstract][Full Text] [Related]
58. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma].
Kang S; Qin Y; He X; Zhou S; Han X; Liu P; Dong M; Zhou L; Yang J; Yang S; Zhang C; Gui L; Shi Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2594-8. PubMed ID: 26711606
[TBL] [Abstract][Full Text] [Related]
59. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
[TBL] [Abstract][Full Text] [Related]
60. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
